Physician profile
Jack C Durham
NPI 1255371381
$3,952.55
in general payments reported to CMS, 2019-2025
39 companies · $64.58 in 2025
The $64.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $431 · 2021: $923 · 2022: $708 · 2023: $574 · 2024: $706 · 2025: $64.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $719.00 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $525.05 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $413.10 | 2019-2024 | Xifaxan |
| Dexcom, INC. | $284.10 | 2021-2024 | Dexcom G6 Transmitter |
| Amgen INC. | $253.82 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Astrazeneca Pharmaceuticals LP | $253.65 | 2019-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $157.80 | 2019-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $113.66 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Allergan, INC. | $95.90 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $89.83 | 2021-2022 | |
| Pfizer INC. | $84.68 | 2021-2024 | |
| Esperion Therapeutics, INC. | $82.90 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $82.22 | 2019-2023 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $77.11 | 2021 | |
| Bausch Health US, LLC | $74.11 | 2019-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.